Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
102.36
-0.68 (-0.66%)
Jan 31, 2025, 4:00 PM EST - Market closed
Boston Scientific Employees
Boston Scientific had 48,000 employees as of December 31, 2023. The number of employees increased by 3,000 or 6.67% compared to the previous year.
Employees
48,000
Change (1Y)
3,000
Growth (1Y)
6.67%
Revenue / Employee
$331,479
Profits / Employee
$37,354
Market Cap
150.86B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 48,000 | 3,000 | 6.67% |
Dec 31, 2022 | 45,000 | 4,000 | 9.76% |
Dec 31, 2021 | 41,000 | 3,000 | 7.89% |
Dec 31, 2020 | 38,000 | 2,000 | 5.56% |
Dec 31, 2019 | 36,000 | 4,000 | 12.50% |
Dec 31, 2018 | 32,000 | 3,000 | 10.34% |
Dec 31, 2017 | 29,000 | 2,000 | 7.41% |
Dec 31, 2016 | 27,000 | 2,000 | 8.00% |
Dec 31, 2015 | 25,000 | 1,000 | 4.17% |
Dec 31, 2014 | 24,000 | 1,000 | 4.35% |
Dec 31, 2013 | 23,000 | -1,000 | -4.17% |
Dec 31, 2012 | 24,000 | 0 | - |
Dec 31, 2011 | 24,000 | -1,000 | -4.00% |
Dec 31, 2010 | 25,000 | -1,000 | -3.85% |
Dec 31, 2009 | 26,000 | 1,200 | 4.84% |
Dec 31, 2008 | 24,800 | -2,700 | -9.82% |
Dec 31, 2007 | 27,500 | -1,100 | -3.85% |
Dec 31, 2006 | 28,600 | 8,800 | 44.44% |
Dec 31, 2005 | 19,800 | 2,300 | 13.14% |
Dec 31, 2004 | 17,500 | 2,500 | 16.67% |
Dec 31, 2003 | 15,000 | 1,100 | 7.91% |
Dec 31, 2002 | 13,900 | -500 | -3.47% |
Dec 31, 2001 | 14,400 | 680 | 4.96% |
Dec 31, 2000 | 13,720 | 1,105 | 8.76% |
Dec 31, 1999 | 12,615 | -1,385 | -9.89% |
Dec 31, 1998 | 14,000 | 3,000 | 27.27% |
Dec 31, 1997 | 11,000 | 1,420 | 14.82% |
Dec 31, 1996 | 9,580 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
BSX News
- 11 days ago - Top 4 Health Care Stocks You May Want To Dump In Q1 - Benzinga
- 16 days ago - Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation - PRNewsWire
- 17 days ago - Boston Scientific Jumps Ahead of Earnings - FXEmpire
- 24 days ago - Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal - Benzinga
- 24 days ago - Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc. - PRNewsWire
- 4 weeks ago - Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results - PRNewsWire
- 4 weeks ago - Boston Scientific Corporation: Solid Financials And Upward Continuation - Seeking Alpha
- 6 weeks ago - FDA classifies recall of Boston Scientific catheters as 'most serious' - Reuters